TcLand Expression appoints two
New chairman and vp of marketing and commercial operations
The French pioneer in the development of gene expression biomarkers for unmet needs in transplantation and auto-immune disease, has also appointed Patrick Terry as chairman of the Board. Terry, a Board member since 2009, succeeds TcLand Expression ceo Alain Huriez, who had held the position since 2005.
Terry is co-founder of Genomic Health and a founder of the Personalised Medicine Coalition.
You may also like
Manufacturing
Quantoom Biosciences partners with Memorial Sloan Kettering Cancer Center to advance personalised mRNA cancer therapeutics
Quantoom Biosciences will use MSK's proprietary lipid nanoparticle technology, Ncapsulate QCX-002, in the development of personalised RNA-based cancer therapies, with plans to support upcoming Phase I clinical trials
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Research & Development
Formulation meets function: addressing palatability in drug development (part II)
Part I of this article examined the critical role of palatability in patient adherence to treatment regimens, the underlying biological challenges of bitterness in medications and the innovative strategies used to create more acceptable and effective drug formulations
Research & Development
AI-powered Viro3D becomes world’s largest database of human and animal virus proteins
Scientists at the MRC-University of Glasgow Centre for Virus Research have launched a free database containing structural models for 85,000 proteins from 4400 viruses, paving the way for faster development of vaccines and antiviral drugs
Research & Development
Prellis biologics partners with Eli Lilly to advance next-generation human antibody therapeutics
Prellis will combine its EXIS organoid and AntiGen AI platforms with Lilly’s research and development expertise, aiming to accelerate the discovery of fully human antibodies for multiple disease targets